Agilent Technologies announced on Wednesday that it has entered a multiyear distribution agreement with digital pathology firm Proscia to offer its Concentriq Dx* platform.
*Concentriq Dx is CE-marked under IVDR and is available for primary diagnosis in the US during the COVID-19 public health emergency.
Featured Story:
Latest Articles
October 1, 2024